Search Results - "HANAGIRI, T"

Mutations within the tyrosine kinase domain of EGFR gene specifically occur in lung adenocarcinoma patients with a low exposure of tobacco smoking by SUGIO, K, URAMOTO, H, YASUMOTO, K, ONO, K, OYAMA, T, HANAGIRI, T, SUGAYA, M, ICHIKI, Y, SO, T, NAKATA, S, MORITA, M

“…Somatically acquired mutations in the epidermal growth factor receptor (EGFR) gene in lung cancer are associated with significant clinical responses to…”
Get full text

A Study of Surgically Resected Peripheral Non-Small Cell Lung Cancer with a Tumor Diameter of 1.0 CM or Less by Baba, T., Uramoto, H., Kuwata, T., Oka, S., Shigematsu, Y., Nagata, Y., Shimokawa, H., Takenoyama, M., Hanagiri, T., Tanaka, F.

“…Background and Aims: The widespread use of high resolution computed tomography has increased the number of small peripheral lung cancers. This study reviewed…”
Get full text

Prognostic significance of lymphovascular invasion for patients with stage I non-small cell lung cancer by Hanagiri, T, Takenaka, M, Oka, S, Shigematsu, Y, Nagata, Y, Shimokawa, H, Uramoto, H, Yamada, S, Tanaka, F

“…This study retrospectively investigated the clinical significance of lymphovascular invasion (LVI) following a complete resection for stage I non-small cell…”
Get more information

Survival impact of node zone classification in resected pathological N2 non-small cell lung cancer by Baba, Tetsuro, Uramoto, Hidetaka, Kuwata, Taiji, Chikaishi, Yasuhiro, Nakagawa, Makoto, So, Tomoko, Hanagiri, Takeshi, Tanaka, Fumihiro

“…We assessed the prognostic value of the 'Zone-classification' which has been proposed by the Japanese Association for Lung Cancer (JALC) for mediastinal nodal…”
Get full text

Results of a Surgical Resection for Patients with Thymic Carcinoma by Yasuda, M., Hanagiri, T., Oka, S., Uramoto, H., Takenoyama, M., Yasumoto, K.

“…Objectives: This study investigated the clinical features of patients with complete resection of thymic carcinoma. Patients and Methods: The clinical records…”
Get full text

Surgical treatment for patients with descending necrotizing mediastinitis by Oka, S, Hanagiri, T, Takenaka, M, Baba, T, Yasuda, M, Ono, K, Uramoto, H, Takenoyama, M, Yasumoto, K

“…Descending necrotizing mediastinitis (DNM) originating from deep cervical infection is a rare and serious clinical condition with a high mortality rate…”
Get more information

Molecular targeted therapy and tailor-made therapy for lung cancer by Sugio, Kenji, Uramoto, H, Takenoyama, M, Hanagiri, T, Yasumoto, K

“…Somatically acquired mutations in the epidermal growth factor receptor (EGFR) gene in lung cancer are associated with significant clinical responses to…”
Get more information

From tumor antigens to immunotherapy by Coulie, P G, Hanagiri, T, Takenoyama, M

Get full text

Optimal dose of basic fibroblast growth factor for long-segment orthotopic tracheal autografts by Nakanishi, Ryoichi, Nagaya, Nobuyuki, Yoshimatsu, Takashi, Hanagiri, Takeshi, Yasumoto, Kosei

“…When a primary anastomosis of the trachea is not feasible, extensive grafting is required. However, despite the use of omental wrapping for revascularization,…”
Get full text

Early histopathologic features of tracheal allotransplant rejection: a study in nonimmunosuppressed dogs by Nakanishi, R, Shirakusa, T, Hanagiri, T

Get more information

Fas expression in non-small cell lung cancer by Uramoto, H, Osaki, T, Inoue, M, Taga, S, Takenoyama, M, Hanagiri, T, Yoshino, I, Nakanishi, R, Ichiyoshi, Y, Yasumoto, K

Get full text

A Positive Relationship Between Filamin and VEGF in Patients with Lung Cancer by URAMOTO, Hidetaka, AKYÜREK, Levent M, HANAGIRI, Takeshi

“…Induction of angiogenic responses by multiple factors, a crucial step in tumor growth and metastasis, is not completely understood. Recently, involvement of…”
Get full text

The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance by Nakata, Shoji, Sugio, Kenji, Uramoto, Hidetaka, Oyama, Tsunehiro, Hanagiri, Takeshi, Morita, Masaru, Yasumoto, Kosei

“…Aberrant methylation of the promoter CpG island (methylation) is known as a major inactivation mechanism of tumor suppressor and tumor-related genes. In this…”
Get full text

Establishment of an immortalized T-cell line from lung cancer tissue: phenotypic and functional analyses by Imahayashi, Satoru, So, Tomoko, Sugaya, Masakazu, Yasuda, Manabu, Eifuku, Ryozo, Takenoyama, Mitsuhiro, Hanagiri, Takeshi, Yoshimatsu, Takashi, Oyama, Tsunehiro, Yasumoto, Kosei

“…In order to investigate host defense against solid tumors, valuable information could be provided by ex-vivo analyses of functional immune cells in tumor…”
Get full text

Effects of interleukin-12 on in vitro culture with interleukin-2 of regional lymph node lymphocytes from lung cancer patients by HANAGIRI, T, TAKENOYAMA, M, YOSHIMATSU, T, HIRASHIMA, C, YOSHINO, I, NAKANISHI, K, NAGASHIMA, A, NOMOTO, K, YASUMOTO, K

“…In the present study, we carried out a functional analysis of regional lymph node lymphocytes (RLNL) from patients with lung cancer after in vitro activation…”
Get full text

Clinical significance of expression of cancer/testis antigen and down-regulation of HLA class-I in patients with stage I non-small cell lung cancer by Hanagiri, Takeshi, Shigematsu, Yoshiki, Shinohara, Shinji, Takenaka, Masaru, Oka, Sohich, Chikaishi, Yasuhiro, Nagata, Yoshika, Baba, Tetsuro, Uramoto, Hidetaka, So, Tomoko, Yamada, Sohsuke

“…The purpose of this study was to investigate the clinical significance of expression of cancer/testis (CT) antigen and down-regulation of HLA class-I in…”
Get full text

Correlation between Tumor Regression and T Cell Responses in Melanoma Patients Vaccinated with a MAGE Antigen by Lonchay, Christophe, van der Bruggen, Pierre, Connerotte, Thierry, Hanagiri, Takeshi, Coulie, Pierre, Colau, Didier, Lucas, Sophie, Van Pel, Aline, Thielemans, Kris, van Baren, Nicolas, Boon, Thierry

“…The cancer-germline gene MAGE-3 codes for tumor-specific antigens recognized on many tumors by T lymphocytes. A MAGE-3 antigen presented by HLA-A1 has been…”
Get full text

Interleukin-12 enhances the antitumor activity of cytotoxic T lymphocytes against lung adenocarcinoma engrafted in severe combined immunodeficient mice by Hanagiri, T., Imahayashi, S., Yoshino, I., So, T., Eifuku, R., Yoshimatsu, T., Takenoyama, M., Osaki, T., Nakanishi, R., Ichiyoshi, Y., Nomoto, K., Yasumoto, K.

“…Background. Through a number of biologic activities, interleukin 12 (IL-12) has proven to be a potential antitumor cytokine in mice bearing a variety of…”
Get full text

Adoptive immunotherapy using specific cytotoxic T lymphocytes against human lung-cancer-engrafted severe combined immunodeficiency mice by Imahayashi, S, Yoshino, I, Eifuku, R, Takenoyama, M, Hanagiri, T, Yasumoto, K

“…We studied the ability of human lung-cancer-specific cytotoxic T lymphocytes to suppress the growth of human lung adenocarcinoma (PC-9) engrafted in severe…”
Get full text

Epidermal growth factor receptor mutations are associated with gefitinib sensitivity in non-small cell lung cancer in Japanese by Uramoto, Hidetaka, Sugio, Kenji, Oyama, Tsunehiro, Ono, Kenji, Sugaya, Masakazu, Yoshimatsu, Takashi, Hanagiri, Takeshi, Morita, Masaru, Yasumoto, Kosei

“…The protein-kinase family is the most frequently mutated gene family found in human cancer. Gefitinib, an ATP-competitive inhibitor of epidermal growth factor…”
Get full text